Report Finds Lax Oversight Of Specialty Pharmacies
A congressional investigation finds that specialty pharmacies like the one that triggered a deadly meningitis outbreak last year get little state oversight.
The new report from House Democrats shows that most states do not track or routinely inspect compounding pharmacies and that pharmacy boards in nearly all 50 states lack the information and expertise they need